These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
271 related articles for article (PubMed ID: 36050819)
1. Clopidogrel versus ticagrelor in East Asian patients aged 75 years or older with acute coronary syndrome: observations from the GF-APT registry. Xi Z; Qiu Z; Li J; Qiu H; Guo T; Wang Y; Zheng J; Gao Y; Gao R Platelets; 2022 Nov; 33(8):1270-1278. PubMed ID: 36050819 [TBL] [Abstract][Full Text] [Related]
2. Safety and Efficacy of Ticagrelor versus Clopidogrel in East Asian Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention Treated with Dual Antiplatelet Therapy: A Meta-Analysis of Randomized Controlled Trials. Li J; Wang Q; Wu C; Qu X; Zhang L; He X; Ma S; Qiu M; Wang X Cardiology; 2023; 148(4):363-373. PubMed ID: 37094558 [TBL] [Abstract][Full Text] [Related]
3. Ticagrelor or Clopidogrel After an Acute Coronary Syndrome in the Elderly: A Propensity Score Matching Analysis from 16,653 Patients Treated with PCI Included in Two Large Multinational Registries. Bianco M; Careggio A; Biolè CA; Quadri G; Quiros A; Raposeiras-Roubin S; Abu-Assi E; Kinnaird T; Ariza-Solè A; Liebetrau C; Manzano-Fernàndez S; Boccuzzi G; Henriques JPS; Spirito A; Templin C; Wilton SB; Velicki L; Correia L; Rognoni A; Ugo F; Nunez-Gil I; Fujii T; Durante A; Song X; Kawaji T; Alexopoulos D; Huczek Z; Gonzàlez Juanatey JR; Nie SP; Kawashiri MA; Morbiducci U; Dominguez-Rodriguez A; Destefanis P; Luciano A; De Ferrari GM; Varbella F; Montagna L; D'Ascenzo F; Cerrato E Cardiovasc Drugs Ther; 2021 Dec; 35(6):1171-1182. PubMed ID: 34224052 [TBL] [Abstract][Full Text] [Related]
4. Age- and Sex-Specific Disparities in Outcomes After Ticagrelor Versus Clopidogrel in East Asian Patients. Jang MH; Kim AR; Kim T; Oh HJ; Lee JH; Lee YJ; Kim S; Lee J; Kim JH; Cha SJ; Kim TO; Kang DY; Lee PH; Ahn JM; Park DW; Park SJ; Am J Cardiol; 2023 Nov; 207():237-244. PubMed ID: 37757520 [TBL] [Abstract][Full Text] [Related]
5. In-Hospital Outcomes of Dual Loading Antiplatelet Therapy in Patients 75 Years and Older With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Findings From the CCC-ACS (Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome) Project. Zhao G; Zhou M; Ma C; Huo Y; Smith SC; Fonarow GC; Ge J; Han Y; Liu J; Hao Y; Liu J; Wang X; Taubert KA; Morgan L; Zhao D; Nie S; J Am Heart Assoc; 2018 Mar; 7(7):. PubMed ID: 29602767 [TBL] [Abstract][Full Text] [Related]
6. Net clinical benefit of different strategies of dual antiplatelet therapy in elderly patients: Data from the praise registry. D'Ascenzo F; Elia E; de Filippo O; Manai R; Breviario S; Bruno F; Iannaccone M; Wańha W; Bianco M; Patti G; Raposeiras-Roubin S; Abu-Assi E; Bo M; De Ferrari GM; Conrotto F; Int J Cardiol; 2022 Apr; 353():9-14. PubMed ID: 35090983 [TBL] [Abstract][Full Text] [Related]
7. Clinically Significant Bleeding With Ticagrelor Versus Clopidogrel in Korean Patients With Acute Coronary Syndromes Intended for Invasive Management: A Randomized Clinical Trial. Park DW; Kwon O; Jang JS; Yun SC; Park H; Kang DY; Ahn JM; Lee PH; Lee SW; Park SW; Choi SW; Lee SG; Yoon HJ; Ahn T; Kim MH; Nah DY; Lee SY; Chae JK; Park SJ; Circulation; 2019 Dec; 140(23):1865-1877. PubMed ID: 31553203 [TBL] [Abstract][Full Text] [Related]
8. Assessing the Clinical Treatment Dynamics of Antiplatelet Therapy Following Acute Coronary Syndrome and Percutaneous Coronary Intervention in the US. Wang Y; Cavallari LH; Brown JD; Thomas CD; Winterstein AG JAMA Netw Open; 2023 Apr; 6(4):e238585. PubMed ID: 37067798 [TBL] [Abstract][Full Text] [Related]
9. Impact of Baseline Bleeding Risk on Efficacy and Safety of Ticagrelor versus Clopidogrel in Chinese Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention. Wang HY; Li Y; Xu XM; Li J; Han YL Chin Med J (Engl); 2018 Sep; 131(17):2017-2024. PubMed ID: 30127210 [TBL] [Abstract][Full Text] [Related]
10. Association of Ticagrelor vs Clopidogrel With Major Adverse Coronary Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention. Turgeon RD; Koshman SL; Youngson E; Har B; Wilton SB; James MT; Graham MM JAMA Intern Med; 2020 Mar; 180(3):420-428. PubMed ID: 31930361 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and Safety of Ticagrelor in Comparison to Clopidogrel in Elderly Patients With ST-Segment-Elevation Myocardial Infarctions. Schmucker J; Fach A; Mata Marin LA; Retzlaff T; Osteresch R; Kollhorst B; Hambrecht R; Pohlabeln H; Wienbergen H J Am Heart Assoc; 2019 Sep; 8(18):e012530. PubMed ID: 31538856 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of ticagrelor and clopidogrel in East Asian patients with coronary artery disease undergoing percutaneous coronary intervention. Li J; Qiu H; Yan L; Guo T; Wang Y; Li Y; Zheng J; Tang Y; Xu B; Qiao S; Yang Y; Gao R Curr Med Res Opin; 2020 Nov; 36(11):1739-1745. PubMed ID: 32945695 [TBL] [Abstract][Full Text] [Related]
14. Ticagrelor versus clopidogrel in East Asian patients with acute coronary syndrome: Systematic review and meta-analysis. Misumida N; Aoi S; Kim SM; Ziada KM; Abdel-Latif A Cardiovasc Revasc Med; 2018 Sep; 19(6):689-694. PubMed ID: 29452843 [TBL] [Abstract][Full Text] [Related]
15. Ticagrelor versus clopidogrel in acute myocardial infarction patients with multivessel disease; From Korea Acute Myocardial Infarction Registry-National Institute of Health. Ahn JH; Ahn Y; Jeong MH; Kim JH; Hong YJ; Sim DS; Kim MC; Hwang JY; Yoon JH; Seong IW; Hur SH; Oh SK; J Cardiol; 2020 May; 75(5):478-484. PubMed ID: 31859138 [TBL] [Abstract][Full Text] [Related]
16. Comparison of Ticagrelor and Clopidogrel in Patients With Acute Coronary Syndrome at High Bleeding or Ischemic Risk. Akyuz S; Calik AN; Yaylak B; Onuk T; Eren S; Kolak Z; Mollaalioglu F; Durak F; Cetin M; Tanboga IH Am J Cardiol; 2024 Jan; 210():241-248. PubMed ID: 37875237 [TBL] [Abstract][Full Text] [Related]
17. Risk of Major Bleeding With Potent Antiplatelet Agents After an Acute Coronary Event: A Comparison of Ticagrelor and Clopidogrel in 5116 Consecutive Patients in Clinical Practice. Mullen L; Meah MN; Elamin A; Aggarwal S; Shahzad A; Shaw M; Hasara J; Rashid M; Fisher M; Ali T; Patel B; Ding WY; Grainger R; Heseltine T; Kirmani BH; Obeidat M; Kasolo Y; Thatchil J; Khand A J Am Heart Assoc; 2021 Apr; 10(8):e019467. PubMed ID: 33834845 [TBL] [Abstract][Full Text] [Related]
18. Safety and Effectiveness of Contemporary P2Y Yun JE; Kim YJ; Park JJ; Kim S; Park K; Cho MS; Nam GB; Park DW J Am Heart Assoc; 2019 Jul; 8(14):e012078. PubMed ID: 31310570 [TBL] [Abstract][Full Text] [Related]
19. Comparison of Clinical Outcomes Between Ticagrelor and Clopidogrel in Elderly Patients Undergoing Percutaneous Coronary Intervention: A Cohort Study. Meng S; Guo L; Ye Z; Wang J; Ding H; Wu S; Huang R Clin Interv Aging; 2022; 17():331-341. PubMed ID: 35400997 [TBL] [Abstract][Full Text] [Related]
20. [The efficacy and safety of ticagrelor versus clopidogrel in elderly patients with acute coronary syndrome undergoing percutaneous coronary intervention]. Na K; Li MY; Qiu MH; Li J; Liu R; Li Y; Han YL Zhonghua Xin Xue Guan Bing Za Zhi; 2021 Nov; 49(11):1117-1123. PubMed ID: 34775722 [No Abstract] [Full Text] [Related] [Next] [New Search]